News | Radiation Oncology | July 17, 2019

CMS Proposes New Alternative Payment Model for Radiation Oncology

ASTRO issues statement emphasizing need for radiation oncologists to participate in value-based cancer care

CMS Proposes New Alternative Payment Model for Radiation Oncology

July 17, 2019 — The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM) for radiation oncology on July 10, 2019. In response, the American Society for Radiation Oncology (ASTRO) issued the following statement from Paul Harari, M.D., FASTRO, chair of the ASTRO Board of Directors:

“The Radiation Oncology (RO) Model announced today by the Center for Medicare and Medicaid Innovation (Innovation Center) is a step forward in allowing the nation’s 4,500 radiation oncologists to participate in the transition to value-based care that improves outcomes for cancer patients. We believe that once implemented with modifications, the model will incentivize higher quality, more convenient radiation treatments for patients and support their journey toward a cure,” Harari said.

“We look forward to providing comments on the specifics of the model, including requirements for certain radiation oncology groups to participate. In our comments to CMS, ASTRO will prioritize recommendations that achieve our longstanding payment reform goals, including stable and fair payments accompanied by incentives for higher quality care and lower costs. In addition, ASTRO will look closely for opportunities to ensure the model is consistent with the administration’s initiative to reduce physician burden and paperwork,” he continued.

“ASTRO has worked for many years to craft a viable payment model that would stabilize payments, drive adherence to nationally-recognized clinical guidelines and improve patient care. We appreciate the Administration’s focus and commitment to ensuring radiation oncologists' ability to participate in an advanced APM,” Harari concluded. 

Read the full proposed alternative payment model from CMS.

For more information: www.astro.org

Related Content

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.

News | Coronavirus (COVID-19) | July 09, 2020
July 9, 2020 — With increased lung CT exam paradigms being used in the current...
World's largest radiation oncology meeting will offer full conference on interactive platform October 25-28, 2020
News | ASTRO | July 09, 2020
July 9, 2020 — Registration opens today for the American Society for Radiation Oncology's (...
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
At the American Association of Physicists in Medicine (AAPM) 2019 meeting, new artificial intelligence (AI) software to assist with radiotherapy treatment planning systems was highlighted. The goal of the AI-based systems is to save staff time, while still allowing clinicians to do the final patient review. 
Feature | Treatment Planning | July 08, 2020 | By Melinda Taschetta-Millane
At the American Association of Physicists in Medicine (AAPM) 201
Changes outlined in new draft U.S. Preventive Services Task Force (USPSTF) lung cancer screening recommendations will greatly increase the number of Americans eligible for screening and help medical providers save thousands more lives each year.

Image courtesy of Cerner

News | Lung Imaging | July 08, 2020
July 8, 2020 — Changes outlined in new draft U.S.
Radiotherapy has been used to treat cancers for more than a century and continues to be utilized in cancer treatment plans today. Since the introduction of radiotherapy, clinicians have been working tirelessly to further refine treatments to better target cancer.
Feature | Radiation Therapy | July 06, 2020 | By Yves Archambault
Everything has room for improvement, right? Right. When it comes to cancer care, it is no different.
Proton therapy has evolved, and future predictions include smaller systems, more sophisticated proton dosimetry and devices that manipulate the proton beam
Feature | Proton Therapy | July 06, 2020 | By Minesh Mehta, M.D.
The field of proton...